Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
12,54 SEK | -1,72% | -3,98% | +272,11% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 431 mln. 39,81 mln. 37,21 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -37 mln. -3,42 mln. -3,2 mln. | Nettowinst (verlies) 2025 * | -102 mln. -9,43 mln. -8,81 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | 18,35 mln. 1,7 mln. 1,58 mln. | Nettoliquiditeiten 2025 * | 57 mln. 5,27 mln. 4,92 mln. | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-9,93
x | K/w-verhouding 2025 * |
-5,16
x | Werknemers | 13 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 74,72% |
Recentste transcriptie over Ascelia Pharma AB
1 dag | -3,37% | ||
1 week | -3,98% | ||
Lopende maand | +36,16% | ||
1 maand | +23,91% | ||
3 maanden | +83,60% | ||
6 maanden | +289,44% | ||
Lopend jaar | +272,11% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 49 | 01-01-14 | |
Director of Finance/CFO | 52 | 01-01-20 | |
Chief Tech/Sci/R&D Officer | 40 | 01-01-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 69 | 01-06-17 | |
Niels Mengel
BRD | Director/Board Member | 76 | 01-01-00 |
Director/Board Member | 59 | 01-01-17 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
23-04-24 | 12,54 | -1,72% | 186 740 |
22-04-24 | 12,76 | -3,19% | 144 180 |
19-04-24 | 13,18 | -5,04% | 103 820 |
18-04-24 | 13,88 | -0,14% | 274 963 |
17-04-24 | 13,9 | +6,43% | 502 823 |
uitgestelde koers Nasdaq Stockholm, 23 april 2024 om 17:29 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+272,11% | 39,46 mln. | |
+2,54% | 42,11 mld. | |
+48,83% | 40,08 mld. | |
+7,94% | 40 mld. | |
-10,82% | 26,87 mld. | |
+7,40% | 24,58 mld. | |
-23,80% | 18,44 mld. | |
+1,48% | 11,94 mld. | |
+31,18% | 11,66 mld. | |
+7,49% | 11,01 mld. |